503 Compounding: Challenges, Compliance & the Road Ahead
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
-
Lu par :
-
De :
À propos de ce contenu audio
In this episode of RCA Radio, host Brandon Miller is joined by RCA experts Anita Michael and Arie Anahory for a deep dive into the evolving world of compounding pharmacies. Together, they explore the critical role compounders play in personalized medicine, their differences from traditional pharmaceutical manufacturers, and the increasing regulatory scrutiny they face—especially 503B outsourcing facilities.
The discussion covers:
- The origins and types of compounding pharmacies (503A vs. 503B)
- Regulatory challenges post-New England Compounding Center crisis
- Key compliance hurdles including aseptic processing and FDA inspections
- Practical advice for both new and established compounders to stay compliant
Whether you're entering the compounding space or navigating the latest compliance expectations, this episode offers timely insights and actionable guidance.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
Aucun commentaire pour le moment